Stephen Oroszlan
#160,617
Most Influential Person Now
Stephen Oroszlan's AcademicInfluence.com Rankings
Stephen Oroszlanbiology Degrees
Biology
#12698
World Rank
#16192
Historical Rank
Microbiology
#755
World Rank
#831
Historical Rank
Immunology
#853
World Rank
#876
Historical Rank
Download Badge
Biology
Why Is Stephen Oroszlan Influential?
(Suggest an Edit or Addition)Stephen Oroszlan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. (1983) (640)
- Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. (1986) (473)
- Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. (1985) (433)
- Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. (1985) (412)
- Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. (1985) (355)
- Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. (1985) (311)
- Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II. (1981) (243)
- Fatty acylation of proteins. (1988) (238)
- Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. (1992) (227)
- Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. (1985) (222)
- Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. (1986) (210)
- Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. (1982) (206)
- Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. (1983) (205)
- Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. (1985) (203)
- Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses (1986) (202)
- A micromethod for complete removal of dodecyl sulfate from proteins by ion-pair extraction. (1979) (197)
- Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. (1983) (188)
- Ubiquitin Is Covalently Attached to the p6GagProteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the p12Gag Protein of Moloney Murine Leukemia Virus (1998) (184)
- Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. (1986) (175)
- Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24 (1988) (175)
- Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne) (1988) (163)
- Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. (1988) (159)
- In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid (1983) (157)
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteins (1991) (156)
- Interactions of retroviral structural proteins with single-stranded nucleic acids. (1987) (141)
- Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products (1984) (140)
- Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. (1988) (138)
- Inhibition of human immunodeficiency virus infectivity by chloroquine. (1990) (136)
- Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. (1981) (136)
- Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus (1982) (127)
- Translational Suppression in Retroviral GENE Expression (1992) (114)
- Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23. (1993) (113)
- Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III (1987) (107)
- Retroviral proteinases. (1990) (105)
- Kinetic and modeling studies of S3-S3' subsites of HIV proteinases. (1992) (104)
- Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. (1987) (99)
- Capsid protein VP4 of poliovirus is N-myristoylated. (1987) (97)
- Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. (1987) (96)
- Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses. (1982) (95)
- Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus (1990) (90)
- Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. (1984) (87)
- Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease (1985) (86)
- Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. (1984) (84)
- Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene (1979) (80)
- Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. (1986) (78)
- Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins (1987) (78)
- Chromatographic analysis of the aminoacyl-trnas which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV (1989) (75)
- Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. (1990) (74)
- Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support. (1980) (74)
- Studies on the role of the S4 substrate binding site of HIV proteinases (1991) (71)
- Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. (1990) (71)
- Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins (1986) (70)
- Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein (1985) (69)
- Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences. (1983) (69)
- Complete amino acid sequence of human T‐cell leukemia virus structural protein p15 (1983) (68)
- Characterization of ribosomal frameshifting for expression of pol gene products of human T-cell leukemia virus type I (1993) (67)
- Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor. (1990) (67)
- Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus. (1990) (66)
- The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. (1993) (66)
- Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease. (1988) (65)
- The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. (1989) (65)
- Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli. (1991) (64)
- The where, what and how of ribosomal frameshifting in retroviral protein synthesis (1990) (64)
- Transfer RNA modification status influences retroviral ribosomal frameshifting. (1999) (64)
- Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase (1994) (62)
- Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases. (2000) (61)
- Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. (1987) (60)
- Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. (1990) (59)
- Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera. (1985) (59)
- Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. (1995) (59)
- Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus (1985) (56)
- Stabilization from Autoproteolysis and Kinetic Characterization of the Human T-cell Leukemia Virus Type 1 Proteinase* (1999) (56)
- Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. (1985) (54)
- Amino Acid Sequence Analysis of Reverse Transcriptase Subunits from Avian Myeloblastosis Virus (1980) (54)
- Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. (1985) (51)
- Isolation and sequence analysis of cDNA clones coding for rat skeletal muscle creatine kinase. (1984) (48)
- In situ processing of a retroviral nucleocapsid protein by the viral proteinase. (1991) (47)
- Structure and function of suppressor tRNAs in higher eukaryotes. (1990) (47)
- HIV-1 proteinase is required for synthesis of pro-viral DNA. (1991) (46)
- Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence. (1984) (45)
- Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. (1989) (44)
- Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins. (1978) (44)
- Viral Proteinases As Targets for Chemotherapy (1989) (43)
- Murine leukemia virus gag polyproteins: the peptide chain unique to Pr80 is located at the amino terminus. (1978) (43)
- Chemical synthesis and expression of the HIV-1 protease gene in E. coli. (1989) (43)
- Narrow Substrate Specificity and Sensitivity toward Ligand-binding Site Mutations of Human T-cell Leukemia Virus Type 1 Protease* (2004) (43)
- Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. (1990) (42)
- Phosphorylation of the Rex protein of human T-cell leukemia virus type I. (1992) (41)
- Tunicamycin inhibits glycosylation of precursor polyprotein encoded by env gene of Rauscher murine leukemia virus. (1979) (41)
- Studies on the Symmetry and Sequence Context Dependence of the HIV-1 Proteinase Specificity* (1997) (40)
- Effect of substrate residues on the P2' preference of retroviral proteinases. (1999) (39)
- Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity (1994) (39)
- Analysis of gag proteins from mouse mammary tumor virus (1989) (38)
- Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme. (1993) (36)
- Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. (1985) (36)
- Complete amino acid sequence of the basic nucleic acid binding protein of feline leukemia virus. (1984) (34)
- Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates. (1993) (33)
- Binding of human prothymosin alpha to the leucine-motif/activation domains of HTLV-I Rex and HIV-1 Rev. (1995) (33)
- Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope. (1986) (33)
- Synthetic non-peptide inhibitors of HIV protease. (1989) (32)
- The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells (1991) (32)
- Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity. (1989) (32)
- The envelope proteins of bovine leukemia virus: purification and sequence analysis. (1984) (32)
- Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. (1997) (32)
- Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli. (1992) (31)
- Gene order of the mouse mammary tumor virus glycoproteins. (1977) (31)
- Amino-terminal amino acid sequence and carboxyl-terminal analysis of Rauscher murine leukemia virus glycoproteins. (1978) (30)
- Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase. (1985) (29)
- Proteolytic events of HIV-1 replication as targets for therapeutic intervention. (2003) (28)
- Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural proteins. (1985) (28)
- Effect of Chemical Modification and Fragmentation on Antigenic Determinants of Internal Protein p30 and Surface Glycoprotein gp70 of Type C Retroviruses (1980) (28)
- Structure of glycosylated and unglycosylated gag polyproteins of Rauscher murine leukemia virus: carbohydrate attachment sites (1981) (27)
- Isolation and characterization of low-molecular-weight DNA-binding proteins from retroviruses. (1980) (27)
- Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease. (1994) (27)
- Development of methodology for the synthesis of stereochemically pure Phe.psi.[CH2N]Pro linkages in HIV protease inhibitors (1991) (26)
- Identification of simian immunodeficiency virus SIVMAC env gene products (1989) (25)
- Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase. (1989) (25)
- A region of basic amino-acid cluster in HIV-1 Tat protein is essential forTrans-acting activity and nucleolar localization (1989) (25)
- Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit. (1997) (24)
- Rhesus Monkey Simian Immunodeficiency Virus Infection as a Model for Assessing the Role of Selenium in AIDS (2002) (23)
- Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease. (2006) (22)
- Lysis of retroviruses with monoclonal antibodies against viral envelope proteins. (1980) (22)
- Biosynthesis and chemical and immunological characterization of avian reticuloendotheliosis virus env gene-encoded proteins. (1986) (22)
- Structural and antigenic analysis of the nucleic acid-binding proteins of bovine and feline leukemia viruses (1983) (21)
- Identification and characterization of c-raf phosphoproteins in transformed murine cells. (1988) (21)
- Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins. (1985) (21)
- Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains (1992) (21)
- Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1 (2014) (20)
- Solid phase synthesis of the proteinase of bovine leukemia virus Comparison of its specificity to that of HIV‐2 proteinase (1992) (20)
- C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope. (1986) (20)
- Molecular model of equine infectious anemia virus proteinase and kinetic measurements for peptide substrates with single amino acid substitutions. (1993) (20)
- Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product (1982) (19)
- Biological, Chemical, and Immunological Studies of Rauscher Ecotropic and Mink Cell Focus-Forming Viruses from JLS-V9 Cells (1983) (18)
- Site-directed cytotoxic antibody against the C-terminal segment of the surface glycoprotein gp90 of avian reticuloendotheliosis virus. (1988) (18)
- Expression and characterization of human foamy virus proteinase (1999) (18)
- PROCESSING AND STRUCTURE OF MURINE LEUKEMIA VIRUS gag AND env GENE ENCODED POLYPROTEINS (1980) (18)
- Novel glycosylation pathways of retroviral envelope proteins identified with avian reticuloendotheliosis virus (1988) (18)
- Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli. (2004) (18)
- Mutational Analysis of the Substrate Binding Pocket of Murine Leukemia Virus Protease and Comparison with Human Immunodeficiency Virus Proteases (*) (1995) (18)
- Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase. (2000) (17)
- Abelson murine leukemia virus P120: identification and characterization of tyrosine phosphorylation sites (1982) (17)
- Terminal amino acid sequences and proteolytic cleavage sites of mouse mammary tumor virus env gene products (1983) (17)
- Glycoproteins of friend murine leukemia virus: separation and NH2-terminal amino acid sequences of gp69 and gp71 (1982) (16)
- Bovine leukemia virus post-envelope gene coded protein: evidence for expression in natural infection. (1985) (16)
- The env-gene of the spleen focus-forming virus lacks expression of p15(E) determinants. (1980) (16)
- Mr75,000 PROTEIN, A TUMOR MARKER IN RENAL ADENOCARCINOMA, REACTING WITH ANTIBODIES TO A SYNTHETIC PEPTIDE BASED ON A CLONED HUMAN ENDOGENOUS RETROVIRAL NUCLEOTIDE SEQUENCE (1985) (16)
- Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates. (1999) (15)
- Reactivity of a sulfhydryl group of the ras oncogene product p21 modulated by GTP binding. (1986) (15)
- Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate. (1992) (14)
- Activity of linked HIV-1 proteinase dimers containing mutations in the active site region. (1996) (14)
- Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers. (1998) (14)
- A solid phase assay for the protease of human immunodeficiency virus. (1990) (14)
- Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site. (2006) (13)
- Complete amino acid sequence of the group-specific antigen gene-encoded phosphorylated proteins of mouse leukemia viruses. (1982) (13)
- Immunopurification of the suppressor tRNA dependent rabbit beta-globin readthrough protein. (1988) (12)
- Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis. (2003) (12)
- Role of Nonsense, Frameshift, and Missense Suppressor tRNAs in Mammalian Cells (1990) (12)
- The Action of Retroviral Protease in Various Phases of Virus Replication (1990) (11)
- Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer. (1991) (11)
- Inhibition of lymphocyte proliferation by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. (1985) (10)
- Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells. (1996) (10)
- The met oncogene: a new member of the tyrosine kinase family and a marker for cystic fibrosis. (1986) (10)
- Isolation and characterization of alpha 2-macroglobulin-protease complexes from purified mouse mammary tumor virus and culture supernatants from virus-infected cell lines. (1992) (9)
- Reversed Phase (RP) HPLC of Proteins and Peptides and Its Impact on Protein Microsequencing (1982) (9)
- Genome organization of a biologically active molecular clone of the lymphoproliferative disease virus of turkeys. (1994) (8)
- Inhibition of bacterially expressed HIV protease activity determined by an in vitro cleavage assay with MuLV Pr65gag. (1989) (7)
- Studies of the autoprocessing of the HIV-1 protease using cleavage site mutants. (1991) (7)
- Amino- and carboxyl-terminal sequences of proteins coded by gag gene of endogenous baboon and cat type C viruses. (1981) (6)
- Expression of type C virus p30 in mouse cells infected with herpes simplex virus. (1977) (5)
- Tyrosine phosphorylation sites common to transforming proteins encoded by Gardner and Snyder-Theilen FeSV. (1982) (5)
- In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence. (2004) (5)
- Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses. (1984) (5)
- In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30. (1985) (5)
- Regulated Proteolytic Processing within Mature Retroviral Capsids (1991) (4)
- Application of radioimmunologic techniques to studies of the epidemiologic involvement of bovine leukemia virus in lymphosarcoma of domestic cattle. (1978) (3)
- Moloney murine leukemia virus retropepsin (2004) (3)
- Chemical synthesis of a retroviral nucleic acid binding protein (1988) (3)
- Phosphorylation of human interleukin-2 (IL-2) (1989) (3)
- An Approach to the Synthesis of HIV Protease Inhibitors (1990) (2)
- Totally Synthetic Retroviral Proteins: Proteases and Nucleic Acid Binding Proteins, (1992) (2)
- Amino-terminal sequence of bovine leukemia virus major internal protein : Homology with mammalian type C virus p 30 structural proteins ( amino acid sequence homology / feline leukemia virus (2)
- Characterization of Immunoaffinity-Purified Human T-Cell Growth Factor from JURKAT Cells (1984) (2)
- Replication-dependent fitness recovery of Human immunodeficiency virus 1 harbouring mutations of Asn17 of the nucleocapsid protein. (2006) (2)
- Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein (2021) (1)
- Mechanisms of Ribosomal Frameshifting for Synthesis of the Protease in HIV and other Retroviruses and the Possible Use of Hypomodified tRNAs in the Frameshift Event (1989) (1)
- SYNTHESIS AND POST-TRANSLATIONAL MODIFICATION OF RETROVIRUS PRECURSOR POLYPROTEINS ENCODED BY gag AND env GENES (1979) (0)
- Equine Infectious Anemia Virus Retropepsin (2004) (0)
- Amino- and carboxyl-terminal ami coded by gag gene of murine leuke) (2016) (0)
- Immunological characterization of the natural antibodies to human T-cell leukemia virus in human sera. (1983) (0)
- Topoisomerase Iactivity associated withhuman immunodeficiency virus (HIV) particles andequine infectious anemiavirus core (1990) (0)
- Primary structure analysis of the n human type C T-cell leukemia virus (human RNA tumor virus/bovine leukemia virus/retrovirus proteins (2016) (0)
- Mouse mammary tumor virus retropepsin (2004) (0)
- Isolation ofa Lentivirus froma MacaquewithLymphoma: Comparison withHTLV-III/LAV andOtherLentiviruses (1986) (0)
- Characterization of the TPR-MET oncogene p 65 and the MET protooncogene p 140 protein-tyrosine kinases ( cell-surface receptor / phosphorylation / expression in tumor cell lines / expression in Escherichia cola ) (0)
- Structural proteins of HTLV-III/LAV (1987) (0)
- Complementary Peptides as Inhibitors of HIV-1 Protease, (1992) (0)
- Characterization oftheTPR-METoncogene p65andtheMET protooncogene p140protein-tyrosine kinases (cell-surface receptor/phosphorylation/expression intumor cell lines/expression inEscherichia cola) (1988) (0)
- Purification and Characterization of the Mouse Mammary Tumor Virus Protease Expressed in Escherichia coZi * (2001) (0)
- Synthesis andProcessing oftheTransmembrane Envelope Protein ofEquineInfectious AnemiaVirus (1990) (0)
- Errata (2007) (0)
This paper list is powered by the following services:
